Issue link: https://www.e-digitaleditions.com/i/1521797
News on R&D and progress in the treatment of respiratory diseases, such as asthma and COPD. Calendar: The industry organizations page of the Inhalation website provides descriptions and contact information for cross-industry organizations and groups that present educational conferences and workshops Inhalation June 2024 35 INDUSTRY NEWS continued from page 8 SIS Ventures, Ascension and Con- duit EIS Impact Fund. In addi- tion, Nebu-Flow was recently awarded a £1m project from Innovate UK, the United King- dom's national innovation agency. Business Wire noted the compa- ny's nebulizer platform has been developed to provide a number of advantages over existing tech- nologies. "We are engaged with a number of partners in the UK and North America who are currently trialling the product as we prepare for the regulatory approval stage," said Elijah Nazarzadeh, PhD, CEO and Cofounder. RESPIRATORY MEDICINE NEWS Food allergies in infants and asthma development later VICTORIA, AUSTRALIA— StudyFinds.org reported results of research conducted by the Mur- doch Children's Research Institute in Australia, which showed that babies who suffer from food aller- gies have a greater risk of devel- oping asthma and experiencing reduced lung function as they grow up. e study was published in e Lancet Child & Adolescent Health. Researchers observed 5,276 infants from the HealthNuts study, using skin prick tests to detect common food allergens such as peanut and egg. e children then took part in oral food challenges to confirm food allergies. At the age of six, these tests were repeated, along with lung function tests. By the age of six, 13.7 percent of the children in the study had been diagnosed with asthma. ose who had food allergies as babies were nearly four times more likely to have asthma, compared to those who did not have food allergies in infancy. at likelihood was higher for children whose food allergies continued until they were six. In addition, children with food allergies were more likely to have reduced lung growth. In a news release, Rachel Peters, Associate Professor at Murdoch Children's Research Institute, said "is association is concern- ing given reduced lung growth in childhood is associated with health problems in adulthood including respiratory and heart conditions. [In addition,] this could explain the link between food allergy and lung function." CALENDAR Please visit the industry organi- zations page of the Inhalation website to find descriptions and contact information for cross- industry organizations and groups that present educational confer- ences and workshops. https://www.inhalationmag.com/ industry-organizations ADVERTISER INDEX B Biomerics 7 C Catalent Cover 2 Copley Scientific 3 D DDL 37 I Intertek 5 M MKON 27 MSP 31 P Proveris 9 Q Qualicaps 17 R RDD 1 S S-Matrix 35 • Centrally manage all projects, product testing configurations, and apparatuses. • Create re-usable workflow templates for all testing, analytics, and reporting. • Supports all USP / Ph. Eur. apparatuses and configurations. Fully supports 21 CFR 11 compliance. • Full bi-directional CDS automation for ChemStation, Chromeleon ™ , and Empower ™ . • Companion module for formulation and device design R&D. Fusion Inhaler Testing Software ™ The only fully automated software solution for OINDP R&D and QC! www.smatrix.com sales@smatrix.com